Page 85 - IMO-1-1

Innovative Medicines & Omics Smp43 peptide

breast cancer cell lines have shown that Smp43 can induce systemic toxicity, potentially affecting vital organs such
apoptosis, inhibit proliferation, and reduce metastatic as the liver and kidneys. Comprehensive preclinical and
potential. In animal models of breast cancer, Smp43 has clinical studies are essential to assess safe dosage levels
been shown to reduce tumor growth and metastasis. In and administration regimens. Other side effects may
lung cancer cells, Smp43 induces apoptosis through both include pain, redness, and swelling at the injection site,
intrinsic and extrinsic pathways, inhibits proliferation which are typical of many peptide therapies and usually
through cell cycle arrest, and activates the DNA damage temporary. Local inflammation may occur, especially with
response. It also reduces colon cancer cell migration and intramuscular or subcutaneous injections. There is a risk
invasion by downregulating MMPs, inhibiting EMT, and of unintended immunosuppression or changes in immune
decreasing angiogenesis to limit tumor blood supply. 7,16 function, and the peptide could potentially induce
In leukemia cell lines, Smp43 promotes apoptosis autoimmune responses by altering immune tolerance. 14,28
through caspase activation and mitochondrial disruption Since peptides derived from scorpion venom might
and inhibits cell growth by interfering with critical affect neural tissues, there are concerns about potential
signaling pathways. Various assays, such as MTT and neurotoxic effects, including headaches, dizziness, or
MTS, are used to assess Smp43’s cytotoxic effects on changes in sensory perception. Some venom-derived
cancer cells. Flow cytometry techniques measure apoptosis peptides can influence neuronal excitability, which could
levels, including caspase activity and Annexin-V staining. increase the risk of seizures or convulsions, though
Previous research using mouse models of different cancers specific studies would be needed to confirm this. Systemic
(breast, lung, and colon) has evaluated Smp43’s therapeutic administration of the peptide might lead to gastrointestinal
potential by measuring tumor growth, metastasis, and issues, such as diarrhea or discomfort. There could also be
overall survival. These in vivo studies have also assessed the effects on cardiovascular function, such as changes in blood
safety and potential side effects of Smp43, which are crucial pressure or heart rate, which may require monitoring,
for its development as a therapeutic agent. Smp43 could especially in individuals with existing cardiovascular
be developed as a standalone anticancer treatment or used conditions. Cardiac rhythm alterations might also be a
in combination with chemotherapy, radiation, or targeted concern, necessitating careful assessment during clinical
therapies to enhance efficacy and address resistance. 27 trials. 29
3.2. Smp43’s effects on normal cells: Negative effect Smp43 could interact with other drugs or therapies,
Managing potential side effects is critical when using potentially affecting their effectiveness or increasing the
naturally derived therapeutic agents like Smp43, which is risk of adverse effects. Therefore, thorough drug interaction
derived from scorpion venom. Smp43 has been shown to studies are necessary. Preclinical studies should be
have side effects on different biological systems (Table 2). conducted in animal models to identify potential toxicity,
Common side effects include redness, itching, swelling, organ-specific effects, and maximum tolerated doses.
and rash at the injection site, or even systemic reactions, Assessing allergenicity in preclinical studies is important
with severe cases potentially leading to anaphylaxis, a to detect possible allergic reactions. Dose-escalation
serious, life-threatening allergic reaction. As a derivative of studies will help establish the maximum safe dose and
scorpion venom, Smp43 might provoke immune responses observe dose-dependent side effects. During clinical trials,
in certain individuals, leading to allergic reactions. High close patient monitoring for adverse effects is essential,
doses or prolonged use of Smp43 could also result in with protocols in place for managing and mitigating these

Table 2. Potential side effects of Smp43 peptide on different biological systems

Category Potential side effects of Smp43 peptide
Local reactions Mild irritation or redness at the site of application or injection 14
Allergic reactions Possible allergic reactions, though rare, include rash, itching, or swelling 14
Toxicity Low toxicity to mammalian cells at therapeutic concentrations, but higher doses may cause cytotoxicity 12
Immune response Potential to modulate immune responses, leading to unintended immune activation or suppression 14
Gastrointestinal effects Nausea or gastrointestinal discomfort if ingested, though unlikely as it is typically administered topically or through injection 14
Systemic effects Minimal systemic side effects at therapeutic doses, but high doses might cause systemic toxicity 28
Long-term effects Unknown long-term effects; ongoing studies are needed to determine the safety of prolonged use 28
Neurological effects Limited data are available, but no significant neurological side effects reported in initial studies 12

Volume 1 Issue 1 (2024) 79 doi: 10.36922/imo.4353